Analysis of the application status of prescription pre-review systems in Yunnan province
- VernacularTitle:云南省处方前置审核系统应用现状分析
- Author:
Fan XU
1
;
Wenjie YIN
2
;
Kejia LI
3
;
Zhengfu LI
4
;
Jie CHEN
5
;
Meixian WU
6
;
Ruixiang CHEN
7
;
Songmei LI
8
;
Guowen ZHANG
9
;
Te LI
10
Author Information
1. Wuhua Campus，the 920th Hospital of Joint Logistics Support Force of PLA，Kunming 650032，China;Yunnan Pharmaceutical Association，Kunming 650051，China
2. Yunnan Pharmaceutical Association，Kunming 650051，China;Dept. of Pharmacy，Yan’an Hospital Affiliated to Kunming Medical University，Kunming 650051，China
3. Yunnan Pharmaceutical Association，Kunming 650051，China;Dept. of Pharmacy，the Second Affiliated Hospital of Kunming Medical University，Kunming 650101，China
4. Yunnan Pharmaceutical Association，Kunming 650051，China;Dept. of Pharmacy，Zhaotong First People’s Hospital，Yunnan Zhaotong 657000，China
5. Yunnan Pharmaceutical Association，Kunming 650051，China;Dept. of Pharmacy，Kunming Third People’s Hospital，Kunming 650041，China
6. Yunnan Pharmaceutical Association，Kunming 650051，China;Dept. of Pharmacy，Guandu District People’s Hospital of Kunming，Kunming 650211，China
7. Yunnan Pharmaceutical Association，Kunming 650051，China;Dept. of Pharmacy，the Third People’s Hospital of Yunnan Province，Kunming 650011，China
8. Yunnan Pharmaceutical Association，Kunming 650051，China;Dept. of Pharmacy，Yunnan Provincial Hospital of Traditional Chinese Medicine，Kunming 650021，China
9. Yunnan Pharmaceutical Association，Kunming 650051，China;The Fifth Affiliated Hospital of Kunming Medical University/Gejiu People’s Hospital，Yunnan Gejiu 661000，China
10. Yunnan Pharmaceutical Association，Kunming 650051，China
- Publication Type:Journal Article
- Keywords:
pre-review;
prescription review;
healthcare institutions;
rational drug use;
capability maturity
- From:
China Pharmacy
2026;37(1):6-10
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To investigate the application status of prescription pre-review systems in healthcare institutions of Yunnan province， evaluate their system functions and management capabilities， and provide a practical basis for promoting rational drug use. METHODS A questionnaire survey was conducted among public healthcare institutions at or above the secondary level in Yunnan province to investigate the deployment status of the systems. A capability maturity assessment framework was constructed， encompassing 6 dimensions and 39 indicators， including real-time prescription review， prescription correlation review， rule setting， evidence-based information support， prescription authority management， and system operation management. This framework was then used to evaluate the institutions that had implemented the pre-review systems. RESULTS A total of 100 valid questionnaires were collected， with 37 institutions having adopted prescription pre-review systems， mainly tertiary hospitals. The system predominantly adopted a modular architecture and was embedded into the hospital information system through application programming interfaces and middleware， providing certain capabilities for real-time prescription risk identification. Evaluation results indicated that basic functions such as reviewing indications， contraindications， and drug compatibility performed well， while deficiencies remained in functions related to parenteral nutrition prescription， review of drug dosage for specific diseases， individual patient characteristic recognition， and rule setting. Moreover， the construction of review centers and establishment of management systems were also not well-developed. CONCLUSIONS The overall application rate of prescription pre-review systems in Yunnan province remains low. System functions and management mechanisms require further improvement. It is recommended to enhance information infrastructure in lower-level institutions and explore regionally unified review models to promote standardized and intelligent development of prescription review practices.
